Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Valeant offers $45.7bn for Botox firm Allergan

Valeant offers $45.7bn for Botox firm Allergan Adding Allergan to its stable would bring a thoroughbred in the form of blockbuster wrinkle-reducer Botox (onabotulinumtoxinA), which account for almost $2bn of Allergan's total net sales of

ASA bans two Botox ads

ASA bans two Botox ads The Independent Healthcare Advisory Service (IHAS) challenged each company's reference to Botox on its respective website homepage. ... the requirement to attend a consultation with a healthcare professional to determine the suitability of Botox.

ABPI reprimands for four pharma firms

ABPI reprimands for four pharma firms Publicly reprimanded by the Prescription Medicines Code of Practice Authority, Allergan successively failed to comply with an undertaking, continuing to claim that Vistabel/Botox was clinically more potent than Bocouture/Xeomin.

Hospira CEO joins board of Kythera

Hospira CEO joins board of Kythera He joined the company following a 16-year stint at Botox developers Allergan, serving as president from 2006. ... This experience in aesthetic products such as Botox will serve him well in his role at Kythera, with the company currently developing

Valeant to slash workforce after Bausch + Lomb takeover

Valeant to slash workforce after Bausch + Lomb takeover Last year it snapped up skincare company Medicis in a $2.6bn deal that added Botox rival Dysport (abobotulinumtoxin A) to its portfolio along with a range of wrinkle treatments, and

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics